Celecoxib versus non-selective non-steroidal anti-Inflammatory drugs and proton pump inhibitors: clinical effectiveness, safety, and cost-effectiveness
CADTH
Record ID 32012000039
English
Authors' recommendations:
Limited evidence showed that celecoxib versus non-COX-2 selective non-steroidal anti-inflammatory drugs (nsNSAIDs) and proton pumps inhibitors (PPIs) had a similar clinical efficacy and safety profile. nsNSAIDs plus PPIs may be marginally more cost-effective versus celecoxib in the management of adult patients with rheumatoid arthritis or osteoarthritis.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.cadth.ca/media/pdf/htis/dec-2011/RC0310-000%20Celecoxib-PPI.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Osteoarthritis
- Arthritis, Rheumatoid
- Pain
- Anti-Inflammatory Agents, Non-Steroidal
- Proton Pump Inhibitors
- Cyclooxygenase 2 Inhibitors
- Pyrazoles
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.